Suchergebnisse - "Gong, Lanqi"

PubPharm (24)

1

Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in HCC

enthalten in: Hepatology (Baltimore, Md.) | 2024

von Luo, J. | Gong, L. | Yang, Y. | +19

2

Targeting MFGE8 secreted by cancer-associated fibroblasts blocks angiogenesis and metastasis in esophageal squamous cell carcinoma

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2023

von Liu, B. | Zhang, B. | Qi, J. | +14

3

Functions of double-negative B cells in autoimmune diseases, infections, and cancers

enthalten in: EMBO molecular medicine | 2023

von Chung, M. | Gong, L. | Kwong, D. | +5

4

Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction

enthalten in: Nature communications | 2023

von Gong, L. | Luo, J. | Zhang, Y. | +19

5

Functions of double‐negative B cells in autoimmune diseases, infections, and cancers

enthalten in: EMBO Molecular Medicine | 2023

von Chung, M. | Gong, L. | Kwong, D. | +5

6

GLIPR1 promotes proliferation, metastasis and 5-fluorouracil resistance in hepatocellular carcinoma by activating the PI3K/PDK1/ROCK1 pathway

enthalten in: Cancer gene therapy | 2022

von Tiu, Y. | Gong, L. | Zhang, Y. | +5

7

Inhibition of lysyl oxidase-like 2 overcomes adhesion-dependent drug resistance in the collagen-enriched liver cancer microenvironment

enthalten in: Hepatology communications | 2022

von Gong, L. | Zhang, Y. | Yang, Y. | +10

8

Publisher Correction : A T cell resilience model associated with response to immunotherapy in multiple tumor types

enthalten in: Nature medicine | 2022

von Zhang, Y. | Vu, T. | Palmer, D. | +14

ErratumFor: Nat Med. 2022 Jul;28(7):1421-1431. - PMID 35501486

9

A T cell resilience model associated with response to immunotherapy in multiple tumor types

enthalten in: Nature medicine | 2022

von Zhang, Y. | Vu, T. | Palmer, D. | +14

ErratumIn: Nat Med. 2022 Oct;28(10):2219. - PMID 35953723

10

Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma

enthalten in: Journal of experimental & clinical cancer research : CR | 2022

von Liu, B. | Fang, X. | Kwong, D. | +13